Key insights from EBMT 2025, including trends in CAR-T, JACIE developments, and the growing demand for contingency services in cell therapy. Read Biovault’s perspective on what’s shaping the future of the field.
The MHRA has granted Biovault Technical a WDA license, enabling the distribution of medicinal products and advancing cell therapy access in Plymouth and the UK.
Following the publication of a report on the devastating cryogenic freezer failure at the Karolinska Institutet (KI) in Sweden in December 2023, we scrutinise our systems and offer some support.
